Search Results - "PASI, K. J" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

The incidence and magnitude of fibrinolytic activation in trauma patients

The incidence and magnitude of fibrinolytic activation in trauma patients

by RAZA, I., DAVENPORT, R., ROURKE, C., PLATTON, S., MANSON, J., SPOORS, C., KHAN, S., De'ATH, H. D., ALLARD, S., HART, D. P., PASI, K. J., HUNT, B. J., STANWORTH, S., MacCALLUM, P. K., BROHI, K.
Published in Journal of thrombosis and haemostasis (01.02.2013)

Get full text

Journal Article

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

by Collins, P., Chalmers, E., Chowdary, P., Keeling, D., Mathias, M., O'Donnell, J., Pasi, K. J., Rangarajan, S., Thomas, A.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2016)

Get full text

Journal Article

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

by Pasi, K. J., Collins, P. W., Keeling, D. M., Brown, S. A., Cumming, A. M., Dolan, G. C., Hay, C. R. M., Hill, F. G. H., Laffan, M., Peake, I. R.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2004)

Get full text

Journal Article

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

by Laffan, M., Brown, S. A., Collins, P. W., Cumming, A. M., Hill, F. G. H., Keeling, D., Peake, I. R., Pasi, K. J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.05.2004)

Get full text

Journal Article

PK‐guided personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in adults with severe haemophilia A

PK‐guided personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in adults with severe haemophilia A

by Lissitchkov, T., Rusen, L., Georgiev, P., Windyga, J., Klamroth, R., Gercheva, L., Nemes, L., Tiede, A., Bichler, J., Knaub, S., Belyanskaya, L., Walter, O., Pasi, K. J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2017)

Get full text

Journal Article

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

by Nolan, B., Mahlangu, J., Perry, D., Young, G., Liesner, R., Konkle, B., Rangarajan, S., Brown, S., Hanabusa, H., Pasi, K. J., Pabinger, I., Jackson, S., Cristiano, L. M., Li, X., Pierce, G. F., Allen, G.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.01.2016)

Get full text

Journal Article

Predicting the outcomes of using longer‐acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis

Predicting the outcomes of using longer‐acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis

by Miners, A. H., Krishnan, S., Pasi, K. J.
Published in Journal of thrombosis and haemostasis (01.11.2016)

Get full text

Journal Article

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

by Shapiro, A. D., Ragni, M. V., Kulkarni, R., Oldenberg, J., Srivastava, A., Quon, D. V., Pasi, K. J., Hanabusa, H., Pabinger, I., Mahlangu, J., Fogarty, P., Lillicrap, D., Kulke, S., Potts, J., Neelakantan, S., Nestorov, I., Li, S., Dumont, J. A., Jiang, H., Brennan, A., Pierce, G. F.
Published in Journal of thrombosis and haemostasis (01.11.2014)

Get full text

Journal Article

Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres

Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres

by Batty, P., Honke, A., Bowles, L., Hart, D. P., Pasi, K. J., Uprichard, J., Austin, S. K.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2015)

Get full text

Journal Article

Fatal postoperative pulmonary embolism in mild haemophilia

Fatal postoperative pulmonary embolism in mild haemophilia

by BUTCHER, J. H., PASI, K. J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2006)

Get full text

Journal Article

Thrombotic risk factors associated with transurethral prostatectomy

Thrombotic risk factors associated with transurethral prostatectomy

by BELL, C. R. W, MURDOCK, P. J. A, PASI, K. J, MORGAN, R. J
Published in BJU international (01.06.1999)

Get full text

Journal Article

A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period

A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period

by Yee, T. T., Taher, A., Pasi, K. J., Lee, C. A.
Published in Clinical and laboratory haematology (01.10.2000)

Get full text

Journal Article

Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor

Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor

by Hilbert, L, Jenkins, P V, Gaucher, C, Meriane, E, Collins, P W, Pasi, K J, Mazurier, C
Published in Thrombosis and haemostasis (01.08.2000)

Get more information

Journal Article

Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate

Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate

by Yee, T T, Cohen, B J, Pasi, K J, Lee, C A
Published in British journal of haematology (01.05.1996)

Get more information

Journal Article

Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product

Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product

by Yee, T T, Williams, M D, Hill, F G, Lee, C A, Pasi, K J
Published in Thrombosis and haemostasis (01.09.1997)

Get more information

Journal Article

A framework for genetic service provision for haemophilia and other inherited bleeding disorders

A framework for genetic service provision for haemophilia and other inherited bleeding disorders

by Ludlam, C. A., Pasi, K. J., Bolton-Maggs, P., Collins, P. W., Cumming, A. M., Dolan, G., Fryer, A., Harrington, C., Hill, F. G. H., Peake, I. R., Perry, D. J., Skirton, H., Smith, M.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2005)

Get full text

Journal Article

Factor VIII inhibitors in haemophiliacs: a single‐centre experience over 34 years, 1964–97

Factor VIII inhibitors in haemophiliacs: a single‐centre experience over 34 years, 1964–97

by Yee, T. T., Pasi, K. J., Lilley, P. A., Lee, C. A.
Published in British journal of haematology (01.03.1999)

Get full text

Journal Article

Access to primary dental care for patients with inherited bleeding disorders

Access to primary dental care for patients with inherited bleeding disorders

by KALSI, H., NANAYAKKARA, L., PASI, K. J., BOWLES, L., HART, D. P.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2012)

Get full text

Journal Article

Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience

Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience

by Batty, P., Chen, Y. -H., Bowles, L., Hart, D. P., Platton, S., Pasi, K. J.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.11.2014)

Get full text

Journal Article

Type 1 von Willebrand disease — a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

Type 1 von Willebrand disease — a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

by NITU-WHALLEY, I. C, LEE, C. A, GRIFFIOEN, A, JENKINS, P. V, PASI, K. J
Published in British journal of haematology (01.02.2000)

Get full text

Journal Article

1
2
3
4
5
6
Next
[6]